Kuros Biosciences Competitors and Similar CompaniesClear all
Merus's competitors and similar companies include Sorrento Therapeutics.
 Merus Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients. |  Sorrento Therapeutics Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
| |
Founding Date | Founding Date 2003 | Founding Date 2006 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Utrecht, NL HQ Cambridge, US | Locations San Diego, US HQ San Diego, US |
Employees | Employees 260 | Employees 31019% decrease |
Valuation ($) | Valuation ($) 3.6 b | Valuation ($) 1.5 m |
Financial | ||
Revenue (est.) | Revenue (est.) $36.1m (FY, 2024) | Revenue (est.) $62.8m (FY, 2022) |
Net income | Net income ($215.3m) (FY, 2024) | Net income ($577.8m) (FY, 2022) |
Funding | ||
Total funding raised | Total funding raised $ 149.3m | Total funding raised $ 42.6m |
For sources of this data, please see the company profile
View Company Profiles
Sorrento Therapeutics
HQ
San Diego, US
Employees
310↓ 19% decrease
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
View company